Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer

Iwama E, Okamoto I, Harada T, Takayama K, Nakanishi Y

OncoTargets and Therapy 2014, 7:375-385

Published Date: 5 March 2014